Llwytho...
Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine
INTRODUCTION: Heart failure with preserved ejection fraction (HFpEF), which comprises approximately 50% of all heart failure patients, is a challenging and complex clinical syndrome that is often thought to lack effective treatments. AREAS COVERED: Despite the common mantra that HFpEF has no effecti...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Opin Pharmacother |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5549674/ https://ncbi.nlm.nih.gov/pubmed/28129699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14656566.2017.1288717 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|